38
Participants
Start Date
June 30, 2006
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2007
alpha-1 proteinase inhibitor (human)
60 mg/kg weekly for 20 weeks
St Lukes-Roosevelt Hospital Center, New York, New York
Temple University Hospital, Philadelphia
Medical University of South Carolina, Charleston
University of Miami School of Medicine, Miami
Cleveland Clinic Foundation, Cleveland
National Jewish Medical and Research Center, Denver
University of Florida College of Medicine, Gainesville
University of Texas Health Center at Tyler, Tyler
University of Cambridge - Cambridge Institute for Medical Research, Cambridge
University Teaching Hospital of Edinburgh, Edinburgh
Lead Sponsor
Grifols Therapeutics LLC
INDUSTRY